Trademark Overview
On Thursday, May 2, 2024, a trademark application was filed for LNJ with the United States Patent and Trademark Office. The USPTO has given the LNJ trademark a serial number of 79401859. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, August 8, 2024. This trademark is owned by L&J Bio Co.,Ltd.. The LNJ trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
Pharmaceutical preparations for the treatment of brain disease using technology capable of passing through the blood-brain barrier (BBB) to deliver therapeutic proteins directly to brain tissue, using the DAT (dual action therapy) platform for medical purposes; pharmaceutical preparations for the treatment of Alzheimer's disease (senile dementia); pharmaceutical preparations for the treatment of brain disease for medical purposes; pharmaceutical preparations for the treatment of central nervous system [CNS] diseases; pharmaceutical preparations for the treatment of neurodegenerative brain diseases for medical purposes; pharmaceutical preparations for the treatment of Parkinson's disease.
Conducting clinical trials in the field of brain, central nervous system diseases; research and development of vaccines and medicines; development of cell therapy products; drug discovery services; scientific research for medical purposes in the area of cancerous diseases; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; medical research laboratory services for predicting disease; medical research laboratory services in the field of the blood-brain barrier (BBB); medical research laboratory services in the field of Alzheimer's disease.
